Cochrane Abstracts
Aripiprazole versus placebo for schizophrenia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Aripiprazole Versus Placebo for Schizophrenia: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436993/1/Aripiprazole_versus_placebo_for_schizophrenia:_Cochrane_systematic_review.
Aripiprazole versus placebo for schizophrenia: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436993/1/Aripiprazole_versus_placebo_for_schizophrenia:_Cochrane_systematic_review. Accessed December 22, 2024.
Aripiprazole versus placebo for schizophrenia: Cochrane systematic review. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436993/1/Aripiprazole_versus_placebo_for_schizophrenia:_Cochrane_systematic_review
Aripiprazole Versus Placebo for Schizophrenia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 22]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436993/1/Aripiprazole_versus_placebo_for_schizophrenia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Aripiprazole versus placebo for schizophrenia: Cochrane systematic review
ID - 436993
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436993/1/Aripiprazole_versus_placebo_for_schizophrenia:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
